Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
Fig 9
Forest plot of risk ratios (with 95% confidence intervals) of hospitalization for heart failure (post-hoc analyses pooling studies of ACE inhibitors and angiotensin-2 receptor blockers) for higher doses versus lower doses in patients with heart failure with reduced ejection fraction.